Skip to content

Neurocognitive differences between anger and disappointment in negotiations.

Neurocognitive differences between anger and disappointment in negotiations. - ADN

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON32873
Enrollment
20
Registered
2009-10-26
Start date
2010-01-22
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

n.a.

Interventions

n.a.

Sponsors

Universiteit Leiden
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Participants between 18 and 25 with no history of neurological disorder/disease and no counter-indications to MRI will be included in this study. All participants will be right-handed native Dutch speakers with normal vision or contact lenses.

Exclusion criteria

Exclusion criteria: Potential participants will be prescreened for contraindications for fMRI, which include metal implants, heart arrhythmia, claustrophobia, and possible pregnancy (in adult females). They will additionally be prescreened for head trauma, premature birth, learning disabilities, and history of neurological or psychiatric illness and/or use of psychotropic medications. Because of the difficulties in interpreting cognitive studies in subjects with Dutch as a second language, only native-Dutch speakers will be asked to participate in the study. Finally, left-handed individuals will be excluded from the study because some left-handers have substantially different brain organization relative to right-handers.

Design outcomes

Primary

MeasureTime frame
We aim to understand how different regions within the PFC and the limbic structures are important for the decision of how much to offer opponents in a negotiation and how these brain regions are influenced by opponents emotions (anger and disappointment). To this end, we will acquire fMRI data and behavioral responses of participants aged 18-25 years.

Secondary

MeasureTime frame
n.a.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)